![Seng Chin Mah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seng Chin Mah
Presidente presso
BIOVERSYS AG
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Seng Chin Mah is currently Chairman at BioVersys AG since 2009 and Independent Director at OSR Holdings, Inc. starting in 2025.
Formerly, Dr. Mah was Chief Executive Officer at Canyon Pharmaceuticals, Inc. and Canyon Pharmaceuticals Group AG from 2009 to 2021, and Director at Novartis Europharm Ltd. from 1997 to 2005.
Education includes an undergraduate degree from the University of London in 1984 and a doctorate from the University of Basel in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIOVERSYS AG 1,31% | 31/12/2025 | 76.358 ( 1,31% ) | 3 M $ | 31/05/2026 |
Posizioni attive di Seng Chin Mah
| Società | Posizione | Inizio |
|---|---|---|
| BIOVERSYS AG | Presidente | 01/01/2009 |
Precedenti posizioni note di Seng Chin Mah
| Società | Posizione | Fine |
|---|---|---|
Canyon Pharmaceuticals, Inc.
 Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Amministratore Delegato | 01/01/2021 |
Canyon Pharmaceuticals Group AG
 Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Amministratore Delegato | 01/01/2021 |
Novartis Europharm Ltd.
 Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direttore/Membro del Consiglio | 01/01/2005 |
Formazione di Seng Chin Mah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canyon Pharmaceuticals Group AG
Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Health Technology |
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
